Results 291 to 300 of about 47,063 (335)

Hyperpigmentation: Looking beyond hydroquinone

Journal of Cosmetic Dermatology, 2022
Hyperpigmentation is the most common complaint in the age group 40–45 years, seeking consultation for skin disorders. Hydroquinone is a commonly used depigmenting agent in clinical practice for treating hyperpigmentation.
N. Charoo
semanticscholar   +1 more source

DISORDERS OF HYPERPIGMENTATION [PDF]

Dermatologic Clinics, 2000
Hyperpigmentation is a common disorder of the skin, particularly in brown-skinned patients. Melasma is a common cause of facial hyperpigmentation and can be resistant to treatment. A combination of topical creams and gels, chemical peels, and sunscreens may be necessary for significant improvement.
Amit G. Pandya, Ian L. Guevara
openaire   +2 more sources

Treatment of Hyperpigmentation

Facial Plastic Surgery Clinics of North America, 2011
Disorders of hyperpigmentation encompass a plethora of pigmentary problems that can range from inherited to acquired. This article focuses on two prevalent disorders of hyperpigmentation and their treatment: melasma and postinflammatory hyperpigmentation.
Maritza Perez, Anthony M. Rossi
openaire   +5 more sources

Postinflammatory Hyperpigmentation

Journal of Cutaneous Medicine and Surgery, 2009
Background: Postinflammatory hyperpigmentation (PIH) commonly occurs in Fitzpatrick skin types III to VI and can have a considerable impact on quality of life. The majority of cases will improve spontaneously, but this can take months or even years to resolve and in some cases can be permanent.
Susan, Taylor, Pearl, Grimes, Joyce, Lim, Sungbin, Im, Harvey, Lui   +4 more
openaire   +2 more sources

Pigmented demodicidosis ‐ an under‐recognized cause of facial hyperpigmentation

International Journal of Dermatology, 2021
There is a paucity of data regarding demodicidosis‐associated facial hyperpigmentation.
Hana Feuerman, L. Atzmony, Mirit Glick, S. Sherman, I. Snast, E. Hodak, R. Segal   +6 more
semanticscholar   +1 more source

Hyperpigmentation in Thyrotoxicosis

JAMA: The Journal of the American Medical Association, 1970
To the Editor:— The signs of thyrotoxicosis have been memorized by medical students for decades; however, changes in skin pigmentation seem to be frequently overlooked. In our experience, alterations in pigmentation have been a useful and interesting physical finding.
Fuad S. Ashkar, Robert F. Miller, Jorge Jacobi   +2 more
openaire   +2 more sources

Dermoscopy of disorders of hyperpigmentation

Pigment International, 2021
Disorders of hyperpigmentation are common in clinical practice and accounts for a large number of dermatology consultation in our country. These disorders, especially with facial involvement can result in tremendous psycho-social impact and are ...
Sunmeet Sandhu, S. Neema, S. Radhakrishnan   +2 more
semanticscholar   +1 more source

Topical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines.

Journal of Drugs in Dermatology, 2021
Cysteamine is an aminothiol naturally present in cells of the human body as an antioxidant resulting from the degradation of Coenzyme A. Physiologically it is well distributed in mammalian tissues. Highly concentrated in human milk, cysteamine acts as an
S. Desai, Corey L Hartman, P. Grimes, Sana Shah   +3 more
semanticscholar   +1 more source